Gos M[au] - Search Results

Year	Number of Results
2002	2
2004	1
2005	3
2006	2
2008	1
2009	4
2010	1
2011	1
2012	3
2013	5
2014	8
2015	5
2016	5
2017	4
2018	9
2019	4
2020	3
2021	8
2022	3
2023	0

1

Newborn screening and gene therapy in SMA: Challenges related to vaccinations.

Kotulska K, Jozwiak S, Jedrzejowska M, Gos M, Ogrodnik M, Wysocki J, Czajka H, Kuchar E. Kotulska K, et al. Among authors: gos m. Front Neurol. 2022 Nov 23;13:890860. doi: 10.3389/fneur.2022.890860. eCollection 2022. Front Neurol. 2022. PMID: 36504644 Free PMC article. Review.

2

Destabilization of mutated human PUS3 protein causes intellectual disability.

Lin TY, Smigiel R, Kuzniewska B, Chmielewska JJ, Kosińska J, Biela M, Biela A, Kościelniak A, Dobosz D, Laczmanska I, Chramiec-Głąbik A, Jeżowski J, Nowak J, Gos M, Rzonca-Niewczas S, Dziembowska M, Ploski R, Glatt S. Lin TY, et al. Among authors: gos m. Hum Mutat. 2022 Dec;43(12):2063-2078. doi: 10.1002/humu.24471. Epub 2022 Oct 2. Hum Mutat. 2022. PMID: 36125428

3

Epigenetic mechanisms of gene expression regulation in neurological diseases.

Gos M. Gos M. Acta Neurobiol Exp (Wars). 2013;73(1):19-37. Acta Neurobiol Exp (Wars). 2013. PMID: 23595281 Free article. Review.

4

Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling.

Kutkowska-Kaźmierczak A, Gos M, Obersztyn E. Kutkowska-Kaźmierczak A, et al. Among authors: gos m. J Appl Genet. 2018 May;59(2):133-147. doi: 10.1007/s13353-017-0423-4. Epub 2018 Feb 1. J Appl Genet. 2018. PMID: 29392564 Review.

5

[Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background].

Landowska A, Rzońca S, Bal J, Gos M. Landowska A, et al. Among authors: gos m. Dev Period Med. 2018;22(1):14-21. doi: 10.34763/devperiodmed.20182201.1421. Dev Period Med. 2018. PMID: 29641417 Free PMC article. Review. Polish.

6

Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.

Abramowicz A, Gos M. Abramowicz A, et al. Among authors: gos m. Dev Period Med. 2014 Jul-Sep;18(3):297-306. Dev Period Med. 2014. PMID: 25182393 Review.

7

[Fragile X syndrome and FMR1-dependent diseases - diagnostic scheme based on own experience .].

Landowska A, Rzońca S, Bal J, Gos M. Landowska A, et al. Among authors: gos m. Dev Period Med. 2018;22(1):22-32. doi: 10.34763/devperiodmed.20182201.2232. Dev Period Med. 2018. PMID: 29641418 Free PMC article. Review. Polish.

8

Genetic basis of neural tube defects. I. Regulatory genes for the neurulation process.

Gos M, Szpecht-Potocka A. Gos M, et al. J Appl Genet. 2002;43(3):343-50. J Appl Genet. 2002. PMID: 12177524 Review.

9

The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.

Bezniakow N, Gos M, Obersztyn E. Bezniakow N, et al. Among authors: gos m. Dev Period Med. 2014 Jul-Sep;18(3):285-96. Dev Period Med. 2014. PMID: 25182392 Review.

10

[Angelman syndrome--the research model of epigenetic mechanisms expression genes regulation].

Szpecht-Potocka A, Gos M, Struniawski R, Bal J. Szpecht-Potocka A, et al. Among authors: gos m. Med Wieku Rozwoj. 2009 Apr-Jun;13(2):123-30. Med Wieku Rozwoj. 2009. PMID: 19837992 Review. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results